Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Stern, M. P.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

RISKS OF INTENSIVE MANAGEMENT OF NIDDM: THE INSULIN HYPOTHESIS

Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents?

right arrow Michael P. Stern, MD

1 January 1996 | Volume 124 Issue 1 Part 2 | Pages 110-116

Recent evidence suggests that non–insulin-dependent diabetes mellitus (NIDDM) and cardiovascular disease, rather than being related as underlying disease and complication, share common genetic and environmental antecedents, that is, they "spring from the same soil." Fetal and early-life nutritional deficiencies appear to predispose persons to both NIDDM and cardiovascular disease in later life. The insulin resistance syndrome, including abdominal obesity, may constitute the intermediate link between fetal and early-life nutritional deficiency and later disease. The insulin resistance syndrome includes insulin resistance, hyperinsulinemia, abdominal obesity, dyslipidemia with high triglyceride and low high-density lipoprotein cholesterol levels, and hypertension. Each element of the insulin resistance syndrome has been firmly established as a risk factor for development of diabetes. In addition, most of these elements are also well-recognized cardiovascular risk factors, although the weight of evidence now suggests that hyperinsulinemia itself is not. This last point is significant because of concern that aggressive insulinization of diabetic patients, which has been proved to reduce microvascular complications, might paradoxically increase the risk for large-vessel atherosclerosis. Available clinical trials suggest that this fear is unwarranted, but definitive trials are needed to resolve this important clinical question.

Author and Article Information
space

From the University of Texas Health Science Center, San Antonio, Texas. For the current author address, see end of text.
Note: This article is one of a series of articles comprising an Annals of Internal Medicine supplement entitled "Risks and Benefits of Intensive Management in Non-Insulin-dependent Diabetes Mellitus: The Fifth Regenstrief Conference." To view a complete list of the articles included in this supplement, please view its Table of Contents.
Requests for Reprints: Michael Stern, MD, Department of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284.




This article has been cited by other articles:


Home page
Therapeutic Advances in Cardiovascular DiseaseHome page
P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan
Review: Obesity and cardiometabolic syndrome in children
Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 61 - 81.
[Abstract] [PDF]


Home page
Diabetes CareHome page
J. M. Miles and M. D. Jensen
Counterpoint: Visceral Adiposity Is Not Causally Related to Insulin Resistance
Diabetes Care, September 1, 2005; 28(9): 2326 - 2328.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. J. Hunt, K. Williams, D. Rivera, D. H. O'Leary, S. M. Haffner, M. P. Stern, and C. Gonzalez Villalpando
Elevated Carotid Artery Intima-Media Thickness Levels in Individuals Who Subsequently Develop Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1845 - 1850.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. H. Golden, A. R. Folsom, J. Coresh, A. R. Sharrett, M. Szklo, and F. Brancati
Risk Factor Groupings Related to Insulin Resistance and Their Synergistic Effects on Subclinical Atherosclerosis: The Atherosclerosis Risk in Communities Study
Diabetes, October 1, 2002; 51(10): 3069 - 3076.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
L. Iacoviello, E. Ciccarone, and M. B. Donati
Review: The genetics of macrovascular disease in diabetes
The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 364 - 368.
[Abstract] [PDF]


Home page
J. Nutr.Home page
D. S. Ludwig, C. B. Ebbeling, M. A. Pereira, and D. B. Pawlak
A Physiological Basis for Disparities in Diabetes and Heart Disease Risk among Racial and Ethnic Groups
J. Nutr., September 1, 2002; 132(9): 2492 - 2493.
[Full Text] [PDF]


Home page
JAMAHome page
M. J. Davies, D. J. Baer, J. T. Judd, E. D. Brown, W. S. Campbell, and P. R. Taylor
Effects of Moderate Alcohol Intake on Fasting Insulin and Glucose Concentrations and Insulin Sensitivity in Postmenopausal Women: A Randomized Controlled Trial
JAMA, May 15, 2002; 287(19): 2559 - 2562.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. V. Howard, B. L. Rodriguez, P. H. Bennett, M. I. Harris, R. Hamman, L. H. Kuller, T. A. Pearson, and J. Wylie-Rosett
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology
Circulation, May 7, 2002; 105 (18): e132 - e137.
[Full Text] [PDF]


Home page
DiabetesHome page
C. B. Whorwood, S. J. Donovan, D. Flanagan, D. I.W. Phillips, and C. D. Byrne
Increased Glucocorticoid Receptor Expression in Human Skeletal Muscle Cells May Contribute to the Pathogenesis of the Metabolic Syndrome
Diabetes, April 1, 2002; 51(4): 1066 - 1075.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
C. Meisinger, B. Thorand, A. Schneider, J. Stieber, A. Doring, and H. Lowel
Sex Differences in Risk Factors for Incident Type 2 Diabetes Mellitus: The MONICA Augsburg Cohort Study
Arch Intern Med, January 14, 2002; 162(1): 82 - 89.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
C. D Byrne
Programming other hormones that affect insulin: Type 2 diabetes
Br. Med. Bull., November 1, 2001; 60(1): 153 - 171.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Perseghin, A. Caumo, M. Caloni, G. Testolin, and L. Luzi
Incorporation of the Fasting Plasma FFA Concentration into QUICKI Improves Its Association with Insulin Sensitivity in Nonobese Individuals
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4776 - 4781.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. A. Nichols, T. A. Hillier, J. R. Erbey, and J. B. Brown
Congestive Heart Failure in Type 2 Diabetes: Prevalence, incidence, and risk factors
Diabetes Care, September 1, 2001; 24(9): 1614 - 1619.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. B. Whorwood, S. J. Donovan, P. J. Wood, and D. I. W. Phillips
Regulation of Glucocorticoid Receptor {{alpha}} and {beta} Isoforms and Type I 11{beta}-Hydroxysteroid Dehydrogenase Expression in Human Skeletal Muscle Cells: A Key Role in the Pathogenesis of Insulin Resistance?
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2296 - 2308.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
T. Takagi, T. Akasaka, A. Yamamuro, Y. Honda, T. Hozumi, S. Morioka, and K. Yoshida
Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: A serial intravascular ultrasound study
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1529 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Takagi, K. Yoshida, T. Akasaka, S. Kaji, T. Kawamoto, Y. Honda, A. Yamamuro, T. Hozumi, and S. Morioka
Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: A serial intravascular ultrasound study
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 731 - 738.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D.W. Laight, M.J. Carrier, and E.E. Anggard
Antioxidants, diabetes and endothelial dysfunction
Cardiovasc Res, August 18, 2000; 47(3): 457 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Katz, S. S. Nambi, K. Mather, A. D. Baron, D. A. Follmann, G. Sullivan, and M. J. Quon
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2402 - 2410.
[Abstract] [Full Text]


Home page
JAMAHome page
F. L. Brancati, W. H. L. Kao, A. R. Folsom, R. L. Watson, and M. Szklo
Incident Type 2 Diabetes Mellitus in African American and White Adults: The Atherosclerosis Risk in Communities Study
JAMA, May 3, 2000; 283(17): 2253 - 2259.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
A C J Ravelli, J H P van der Meulen, C Osmond, D J P Barker, and O P Bleker
Infant feeding and adult glucose tolerance, lipid profile, blood pressure, and obesity
Arch. Dis. Child., March 1, 2000; 82(3): 248 - 252.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. A. Sakkinen, M. Cushman, B. M. Psaty, B. Rodriguez, R. Boineau, L. H. Kuller, and R. P. Tracy
Relationship of Plasmin Generation to Cardiovascular Disease Risk Factors in Elderly Men and Women
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 499 - 504.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. B. Ruige, W. J. J. Assendelft, J. M. Dekker, P. J. Kostense, R. J. Heine, and L. M. Bouter
Insulin and Risk of Cardiovascular Disease : A Meta-Analysis
Circulation, March 17, 1998; 97(10): 996 - 1001.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1996 by the American College of Physicians.